Proposed FDA Rule Will Create “Patient Medical Information”
Published: 04/19/2024
Sources:
- Food and Drug Administration
Relevant To:
- All Healthcare Organizations
In May 2023, the U.S. Food and Drug Administration (FDA) issued a proposed rule to amend its human prescription drug product labeling regulations for Medication Guides that, if finalized, will require a new type of information known as Patient Medication Information (PMI).
PMI is a new type of Medication Guide proposed by FDA, designed to provide concise, easy-to-understand information about prescription medicines for patients.
According to a new update from the FDA, patients often receive…
Sign Up for Free Trial